-
In a prospective, multicenter study, Cristofanilli and colleagues tested 177 patients with clinically detectable metastatic breast cancer for levels of circulating tumor cells both before and after the initiation of various forms of therapy. The response to therapy was followed using standard clinical detection, but blood samples were also collected to determine the burden of tumor cells in the circulation.
-
Erythromycin and the Risk of Sudden Death; Vaccine Shortage Putting Americans At Risk; FDA Actions.
-
The present study involves yet another analysis of the Nurses Health Study, which began in 1976 when 121,700 female registered nurses 30-55 years of age returned a questionnaire about their medical history and health-related behaviors.
-
-
Merck announced on September 30th that it is voluntarily withdrawing rofecoxib (Vioxx) from the worldwide market.
-
Physicians increasingly are aware of the need to provide prophylaxis against venous thrombosis for the medically ill patient in the hospital environment. This article attempts to separate the fact from fiction regarding VTE prophylaxis.
-
Readers looking for the latest reference on family planning methods and practice can obtain the 18th edition of Contraceptive Technology, to be published this summer.
-
While family planning clinicians counsel on the permanency of vasectomy, more men are seeking reversals of the sterilization method. In the United States, approximately 500,000 vasectomies are performed each year. It is estimated that up to 6% of men who undergo voluntary sterilization eventually will request reversal.
-
With the growing popularity of a new approach to sterilization in the form of the Essure device (Conceptus, San Carlos, CA), family planning providers need to update their counseling information in presenting the option to women considering permanent contraception.
-
